STK11 and neoplasm: A previous study has provided that LKB1 loss triggers complex changes in tumor microenvironment, suggesting a potential role in the response to anti-angiogenic treatment.[32] A number of articles have reported the prognostic value of LKB1 expression in tumors among patients with lung cancer and the results remain controversial.